Approval · Notice of Compliance 38346 · 2026
PROSTALUMIN: Notice of Compliance 38346
Issued September 24, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38346
- Date
- September 24, 2026
- Company
- Centre For Probe Development And CommercializationHamilton, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROSTALUMIN | 02571757 | Approved |
Medicinal ingredients
- (18F)PSMA-1007 3.7 GBQ per ML